Results 61 to 70 of about 13,059 (186)

Is Asthma Remission a New Achievable Goal? A Review of the Current Drug‐Related Evidence and Predictors

open access: yesAllergy, EarlyView.
ABSTRACT Advances in asthma therapies have shown that clinical remission may be an achievable therapeutic goal for patients with asthma. This review discusses the current definitions of remission in asthma, the predictors of remission, airway inflammation/epithelial damage in asthma remission, airway remodeling, paradigms in defining remission and ...
Fatma Esra Gunaydin   +4 more
wiley   +1 more source

Pengaruh Pertumbuhan Laba, Konservatisme Akuntansi, Dan Persistensi Laba Terhadap Kualitas Laba

open access: yesJurnal Ekuilnomi
Penelitian ini menelusuri dampak pertumbuhan laba, konservatisme akuntansi, serta persistensi laba terhadap kualitas laba di perusahaan tekstil dan garmen yang tercatat di Bursa Efek Indonesia selama periode 2018 hingga 2024. Populasi penelitian terdiri atas 22 perusahaan, dengan teknik purposive sampling menghasilkan 15 perusahaan atau 105 observasi ...
Nadia Egga Maya Kharisma   +2 more
openaire   +1 more source

The Airway Transcriptome in Type 2 Cytokine Biomarker‐High and ‐Low Severe Asthma

open access: yesAllergy, EarlyView.
This study distinguishes severe asthma–related airway transcriptomic changes from the effects of high‐dose ICS. Most dysregulated genes in severe asthma show concordance with corticosteroid responses. Corticosteroid‐resistant T2‐high asthma featured T2‐high and epithelial barrier gene upregulation, while T2‐low asthma featured Th1/IL‐17 signatures. ASM,
Jiashu Shen   +19 more
wiley   +1 more source

Waspadai Racun Laba-laba dan Racun Abiotis

open access: yes, 2022
Laba-laba ada yang memiliki racun (biotis) seperti halnya makhluk serangga lainnya. Di lain sisi, racun abiotis pun dekat dengan hidup sehari-hari manusia.
openaire   +1 more source

An update on chronic obstructive pulmonary disease

open access: yesSouth African Family Practice, 2016
Chronic obstructive pulmonary disease (COPD) is a leading cause of death worldwide. It is a chronic condition which affects the respiratory system and worsens over time.
Natalie Schellack   +2 more
doaj   +1 more source

In Vitro Performance of Valved Holding Chambers in Paediatric Asthma Controller Therapy

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim Research on the drug delivery of inhaled corticosteroids and combination medications via valved holding chambers (VHCs) with children's breathing patterns is limited. We aimed to evaluate the in vitro performance of commercially available VHCs without facemasks under preschooler breathing conditions, focusing on total delivered dose and ...
Laura Ojanperä   +2 more
wiley   +1 more source

The discovery and development of ensifentrine: A novel inhaled dual PDE3/4 inhibitor having ‘bifunctional’ bronchodilator and anti‐inflammatory activity

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Ensifentrine (formerly called RPL 554) is a novel, first in class, inhaled bifunctional dual PDE3/4 inhibitor for the treatment of chronic respiratory diseases. Ensifentrine exhibits both bronchodilation via PDE3 inhibition and anti‐inflammatory activity via PDE4 inhibition.
Clive Page
wiley   +1 more source

Effectiveness of ICS/LABA and LAMA/LABA in COPD due to biomass

open access: yesERJ Open Research
BackgroundCOPD due to biomass exposure (COPD-B) is highly prevalent in low- and middle-income countries, and there are no clinical trials designed to evaluate the effectiveness of the treatments currently recommended for patients with COPD due to cigarette smoking (COPD-C).
Alejandra Ramírez-Venegas   +14 more
openaire   +3 more sources

Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD

open access: yesInternational Journal of COPD, 2021
Jean Bourbeau,1 Mona Bafadhel,2 Neil C Barnes,3,4 Chris Compton,3 Valentina Di Boscio,3 David A Lipson,5,6 Paul W Jones,3,7 Neil Martin,3,8 Gudrun Weiss,3 David MG Halpin9 1Respiratory Epidemiology and Clinical Research Unit, Department of Medicine ...
Bourbeau J   +9 more
doaj  

NMDA receptor subunit‐dependent analysis of radiprodil inhibition in neonatal male rat substantia nigra dopaminergic neurons

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Radiprodil is a GluN2B subunit selective NMDA receptor negative allosteric modulator which is currently under clinical investigation as a possible anti‐epileptic drug for paediatric use. Our goal was to investigate the inhibition of dopaminergic neuron NMDA responses by radiprodil.
Bangyuan Liu, Alasdair J. Gibb
wiley   +1 more source

Home - About - Disclaimer - Privacy